Suppr超能文献

体外人脑血管内皮细胞内吞的细胞表面蛋白的鉴定

Identification of Cell-Surface Proteins Endocytosed by Human Brain Microvascular Endothelial Cells In Vitro.

作者信息

Ito Shingo, Oishi Mariko, Ogata Seiryo, Uemura Tatsuki, Couraud Pierre-Olivier, Masuda Takeshi, Ohtsuki Sumio

机构信息

Department of Pharmaceutical Microbiology, Faculty of Life Sciences, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan.

Department of Pharmaceutical Microbiology, School of Pharmacy, Kumamoto University, 5-1 Oe-honmachi, Chuo-ku, Kumamoto 862-0973, Japan.

出版信息

Pharmaceutics. 2020 Jun 23;12(6):579. doi: 10.3390/pharmaceutics12060579.

Abstract

Cell-surface proteins that can endocytose into brain microvascular endothelial cells serve as promising candidates for receptor-mediated transcytosis across the blood-brain barrier (BBB). Here, we comprehensively screened endocytic cell-surface proteins in hCMEC/D3 cells, a model of human brain microvascular endothelial cells, using surface biotinylation methodology and sequential window acquisition of all theoretical fragment-ion spectra-mass spectrometry (SWATH-MS)-based quantitative proteomics. Using this method, we identified 125 endocytic cell-surface proteins from hCMEC/D3 cells. Of these, 34 cell-surface proteins were selectively internalized into human brain microvascular endothelial cells, but not into human umbilical vein endothelial cells (HUVECs), a model of human peripheral microvascular endothelial cells. Two cell-surface proteins, intercellular adhesion molecule-1 (ICAM1) and podocalyxin (PODXL), were identified as BBB-localized endocytic cell-surface proteins in humans, using open mRNA and protein databases. Immunohistochemical evaluation confirmed PODXL expression in the plasma membrane of hCMEC/D3 cells and revealed that anti-PODXL antibody-labeled cell-surface PODXL internalized into hCMEC/D3 cells. Immunohistochemistry further revealed that PODXL is localized at the luminal side of human brain microvessels, supporting its potential suitability for translational applications. In conclusion, our findings highlight novel endocytic cell-surface proteins capable of internalizing into human brain microvascular endothelial cells. ICAM1 or PODXL targeted antibody or ligand-labeled biopharmaceuticals and nanocarriers may provide effective targeted delivery to the brain across the BBB for the treatment of central nervous system (CNS) diseases.

摘要

能够内吞进入脑微血管内皮细胞的细胞表面蛋白,是通过血脑屏障(BBB)进行受体介导转胞吞作用的有前景的候选者。在此,我们使用表面生物素化方法和基于全理论碎片离子谱质谱(SWATH-MS)的定量蛋白质组学的序列窗口数据采集技术,对人脑血管内皮细胞模型hCMEC/D3细胞中的内吞性细胞表面蛋白进行了全面筛选。使用该方法,我们从hCMEC/D3细胞中鉴定出125种内吞性细胞表面蛋白。其中,34种细胞表面蛋白被选择性内化进入人脑血管内皮细胞,而未进入人外周微血管内皮细胞模型人脐静脉内皮细胞(HUVECs)。利用开放的mRNA和蛋白质数据库,两种细胞表面蛋白,细胞间黏附分子-1(ICAM1)和足突蛋白(PODXL),被鉴定为人类中BBB定位的内吞性细胞表面蛋白。免疫组织化学评估证实了PODXL在hCMEC/D3细胞的质膜中表达,并显示抗PODXL抗体标记的细胞表面PODXL内化进入hCMEC/D3细胞。免疫组织化学进一步显示PODXL定位于人脑微血管的管腔侧,支持其在转化应用中的潜在适用性。总之,我们的研究结果突出了能够内化进入人脑血管内皮细胞的新型内吞性细胞表面蛋白。ICAM1或PODXL靶向抗体或配体标记的生物药物和纳米载体可能为治疗中枢神经系统(CNS)疾病提供通过BBB向脑的有效靶向递送。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验